Tag: biologics

SHANGHAI and NEW YORK, June 10, 2025 /PRNewswire/ -- Sanyou Biopharmaceuticals, a leading Shanghai-based high-tech biopharmaceutical company specializing in biologics R&D today announced the...

SINGAPORE, June 10, 2025 /PRNewswire/ -- Akesis Biologics, a biotechnology spin-off from the National University of Singapore (NUS), has officially launched its flagship gut...

MannKind to Highlight Data from Recent Pediatric and Adult Studies of Inhaled Insulin (Afrezza®) at American Diabetes Association’s 85th Scientific Session

NEW YORK, June 9, 2025 /PRNewswire/ -- Formation Bio, an AI-driven pharmaceutical company focused on accelerating drug development, today announced the appointment of its first...

The global pharmaceutical packaging market, valued at USD 131 billion, is experiencing robust growth due to the increasing demand for biologics and expanding pharmaceutical industry. Stemming from factors like a rising geriatric population and stringent safety regulations, innovations in injectables and sustainable packaging are pivotal. Dominant regions like the U.S., Germany, and Japan drive market leadership through advanced technologies. Emphasizing sustainability, regulatory compliance remains a challenge, yet the future outlook is positive, propelled by increased demand for eco-friendly and patient-centric solutions.

The global pharmaceutical packaging market, valued at USD 131 billion, is experiencing robust growth due to the increasing demand for biologics and expanding pharmaceutical industry. Stemming from factors like a rising geriatric population and stringent safety regulations, innovations in injectables and sustainable packaging are pivotal. Dominant regions like the U.S., Germany, and Japan drive market leadership through advanced technologies. Emphasizing sustainability, regulatory compliance remains a challenge, yet the future outlook is positive, propelled by increased demand for eco-friendly and patient-centric solutions.

Medicovestor and Sanyou team up to develop first-in-class chemoimmunotherapy ADCs, combining AI antibody tech with novel dual-targeting platforms.

Partnership combines AI-powered protein manufacturing with advanced drug delivery technologies to accelerate timelines and improve therapeutic outcomes. MADISON, Wis. and KANSAS CITY, Mo., June 9,...

The global Excipients Market, valued at $7.8 Billion in 2024, is projected to reach $10.2 Billion by 2030, growing at a CAGR of 4.6%. This comprehensive report analyzes key trends, drivers, and forecasts, emphasizing the essential role of excipients in pharmaceutical formulations. Discover how excipients enhance drug efficacy and patient experience, explore innovations like multifunctional excipients, and gain insights into regional growth trends, notably in the U.S. and China.

The global Excipients Market, valued at $7.8 Billion in 2024, is projected to reach $10.2 Billion by 2030, growing at a CAGR of 4.6%. This comprehensive report analyzes key trends, drivers, and forecasts, emphasizing the essential role of excipients in pharmaceutical formulations. Discover how excipients enhance drug efficacy and patient experience, explore innovations like multifunctional excipients, and gain insights into regional growth trends, notably in the U.S. and China.

The microbial manufacturing site in Chengdu will be equipped with a 15,000L fermenter, enabling the production of 80 to 110 drug substance (DS) batches...

Portage Biotech and Compedica Stock-for-Stock Exchange

NEW YORK, June 7, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of  Savara Inc. ("Savara" or the "Company") (NASDAQ: SVRA). Such...

This report offers deep insights into market dynamics and forecasts, critical for informed business decisions. Key drivers include the rising demand for biologics and stringent cold chain compliance requirements. Technological advances, such as IoT-enabled systems, enhance cooler efficiency and regulatory traceability. The report covers market segments, regional growth trends, and tariff impacts, offering essential data and strategic insights for stakeholders across healthcare and logistics industries.

This report offers deep insights into market dynamics and forecasts, critical for informed business decisions. Key drivers include the rising demand for biologics and stringent cold chain compliance requirements. Technological advances, such as IoT-enabled systems, enhance cooler efficiency and regulatory traceability. The report covers market segments, regional growth trends, and tariff impacts, offering essential data and strategic insights for stakeholders across healthcare and logistics industries.